NCT02143414 Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02129764 Prednisone for Heart Failure Patients With Hyperuricemia Status COMPLETED Phase PHASE2/PHASE3
NCT02123758 A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02119273 Systemic Corticosteroids in the Perioperative Management of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Status WITHDRAWN Phase PHASE4
NCT02116556 Effects of Rifaximin in Patients With Acute Alcoholic Hepatitis Status UNKNOWN Phase PHASE2
NCT02115997 A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis Status COMPLETED Phase PHASE4
NCT02081183 A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis Status TERMINATED Phase PHASE3
NCT02074137 Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE4
NCT02073097 Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT02072863 A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT02058875 Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring Status WITHDRAWN Phase PHASE4
NCT02055820 A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL Status COMPLETED Phase PHASE1/PHASE2
NCT02043587 Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma Status TERMINATED Phase PHASE2
NCT02036489 Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE4
NCT02036463 A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy Status WITHDRAWN Phase PHASE2
NCT02034552 A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) Status COMPLETED Phase PHASE2
NCT02029638 BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance Status TERMINATED Phase PHASE2
NCT02003222 Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01998971 A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma Status COMPLETED Phase PHASE1